Skip to main content
OpenTrials

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,092 public trials 3,997 recruiting studies
Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

NCT06292780

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute/SCRI Denver, Colorado, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 21 locations
View Trial Details
Recruiting

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

NCT05431088

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Smilow Cancer Hospital New Haven, Connecticut, United States
  • Pediatric Hematology / Oncology a division of Kidz Medical services West Palm Beach, Florida, United States
  • St. Mary's Medical Center West Palm Beach, Florida, United States
  • Alpha Clinical Research Georgia Dunwoody, Georgia, United States
View all 80 locations
View Trial Details
Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

NCT05651932

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • UCSF Medical Center - Hematology and Blood and Marrow Transplant Clinic San Francisco, California, United States
  • Mayo Clinic Hospital - Florida Jacksonville, Florida, United States
  • The Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 26 locations
View Trial Details
Recruiting

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

NCT07033598

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute at Emory Atlanta, Georgia, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

NCT06656494

Conditions
Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • NYU Langone Health New York, United States
  • St Vincent's Hospital Sydney, New South Wales, Australia
  • Royal Perth Hospital Perth, Western Australia, Australia
View all 22 locations
View Trial Details

Related conditions